SCYNEXIS SCYX Stock
SCYNEXIS Price Chart
SCYNEXIS SCYX Financial and Trading Overview
| SCYNEXIS stock price | 0.81 USD |
| Previous Close | 2.73 USD |
| Open | 2.71 USD |
| Bid | 0 USD x 1000 |
| Ask | 0 USD x 1000 |
| Day's Range | 2.68 - 2.82 USD |
| 52 Week Range | 1.15 - 3.84 USD |
| Volume | 197.48K USD |
| Avg. Volume | 1.96M USD |
| Market Cap | 100.06M USD |
| Beta (5Y Monthly) | 2.128873 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.44 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 14.5 USD |
SCYX Valuation Measures
| Enterprise Value | 99.46M USD |
| Trailing P/E | N/A |
| Forward P/E | 2.0296297 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 18.080534 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 17.972 |
| Enterprise Value/EBITDA | -1.307 |
Trading Information
SCYNEXIS Stock Price History
| Beta (5Y Monthly) | 2.128873 |
| 52-Week Change | 53.93% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 3.84 USD |
| 52 Week Low | 1.15 USD |
| 50-Day Moving Average | 2.91 USD |
| 200-Day Moving Average | 2.27 USD |
SCYX Share Statistics
| Avg. Volume (3 month) | 1.96M USD |
| Avg. Daily Volume (10-Days) | 512.13K USD |
| Shares Outstanding | 36.52M |
| Float | 33.36M |
| Short Ratio | 4.45 |
| % Held by Insiders | 1.87% |
| % Held by Institutions | 52.98% |
| Shares Short | 1.77M |
| Short % of Float | 6.05% |
| Short % of Shares Outstanding | 4.86% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:10 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -1385.99% |
| Gross Margin | 87.96% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -52.71% |
| Return on Equity (ttm) | -2024.49% |
Income Statement
| Revenue (ttm) | 5.53M USD |
| Revenue Per Share (ttm) | 0.12 USD |
| Quarterly Revenue Growth (yoy) | 64.50% |
| Gross Profit (ttm) | N/A |
| EBITDA | -76099000 USD |
| Net Income Avi to Common (ttm) | -91234000 USD |
| Diluted EPS (ttm) | -1.94 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 54.82M USD |
| Total Cash Per Share (mrq) | 1.5 USD |
| Total Debt (mrq) | 48.75M USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 1.309 |
| Book Value Per Share (mrq) | -0.898 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -82818000 USD |
| Levered Free Cash Flow (ttm) | -47228124 USD |
Profile of SCYNEXIS
| Country | United States |
| State | NJ |
| City | Jersey City |
| Address | 1 Evertrust Plaza |
| ZIP | 07302-6548 |
| Phone | 201 884 5485 |
| Website | https://www.scynexis.com |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 36 |
SCYNEXIS, Inc., a biotechnology company, develops products for the treatment of fungal infections in the United States. It offers BREXAFEMME for the treatment of vulvovaginal candidiasis (VVC) and recurrent VVC. The company's lead product candidate is Ibrexafungerp, an intravenous drug for the treatment of various fungal infections, including invasive candidiasis, refractory invasive fungal infections, invasive aspergillosis, VVC, and recurrent VVC. It has research collaborations with Merck Sharp & Dohme Corp., Hansoh (Shanghai) Health Technology Co., Ltd., Jiangsu Hansoh Pharmaceutical Group Company Limited, and R-Pharm, CJSC to develop and commercialize rights for ibrexafungerp. The company was formerly known as SCYNEXIS Chemistry & Automation, Inc. and changed its name to SCYNEXIS, Inc. in June 2002. SCYNEXIS, Inc. was incorporated in 1999 and is headquartered in Jersey City, New Jersey.
Q&A For SCYNEXIS Stock
What is a current SCYX stock price?
SCYNEXIS SCYX stock price today per share is 0.81 USD.
How to purchase SCYNEXIS stock?
You can buy SCYX shares on the NasdaqGM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for SCYNEXIS?
The stock symbol or ticker of SCYNEXIS is SCYX.
Which industry does the SCYNEXIS company belong to?
The SCYNEXIS industry is Drug Manufacturers-Specialty & Generic.
How many shares does SCYNEXIS have in circulation?
The max supply of SCYNEXIS shares is 38.98M.
What is SCYNEXIS Price to Earnings Ratio (PE Ratio)?
SCYNEXIS PE Ratio is now.
What was SCYNEXIS earnings per share over the trailing 12 months (TTM)?
SCYNEXIS EPS is -0.44 USD over the trailing 12 months.
Which sector does the SCYNEXIS company belong to?
The SCYNEXIS sector is Healthcare.
SCYNEXIS SCYX included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 15603.26 USD — |
+0.1
|
10.08B USD — | 14784.03 USD — | 16292.28 USD — | — - | 10.08B USD — |
| NASDAQ Global Market Composite NQGM | 1638.71 USD — |
-0.55
|
— — | 1547.55 USD — | 1705.12 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 865.57 USD — |
-0.49
|
— — | 828.4 USD — | 890 USD — | — - | — — |
| NASDAQ Composite Total Return I XCMP | 19098.57 USD — |
+0.1
|
— — | 18095.83 USD — | 19941.93 USD — | — - | — — |
- {{ link.label }} {{link}}